Found: 1
Select item for more details and to access through your institution.
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial.
- Published in:
- Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1662
- By:
- Publication type:
- Article